Four regions, one standard. Our manufacturing partnerships are chosen to bring reliable, affordable, quality-assured healthcare closer to the patients who need it.
Our flagship manufacturing brand and the founding facility of the group, operating since 2013. Skims Pharma runs 5 product lines with a combined capacity of over 1 million units, manufacturing pharmaceuticals and food supplements across gastro, anti-infective, pain, respiratory, antimalarial, and nutritional categories. Certified to ISO 9001, 14001, 45001, and meeting both WHO ML3 and EU GMP standards.
Why it matters: a decade of consistent, certified production gives buyers a track record to rely on, not just a promise.
View Skims Pharma on Our Brands →
Visit skimspharmaceuticals.com →
Indicative capability: active pharmaceutical ingredient and finished-formulation partnerships supporting supply reliability and cost-competitive manufacturing.
Why it matters: a resilient ingredient and formulation supply chain means fewer disruptions to the medicines patients depend on.
Indicative capability: regional manufacturing and formulation relationships supporting faster access into South East Asian and neighboring markets.
Why it matters: regional production shortens the distance — and the time — between manufacturing and the patient.
Indicative capability: local and regional manufacturing relationships supporting market-specific registration and distribution efficiency across our served African markets.
Why it matters: local manufacturing relationships reduce dependency on long supply chains, supporting steadier availability where it's needed most.
Four manufacturing regions isn't a scale statement for its own sake. Each partnership exists because it makes quality healthcare more reliable, more affordable, or more locally accessible for the patients at the end of the chain — that's the test every partnership in this network has to pass.
Tell us what you're looking for and where — we'll point you to the right part of our network.
Contact Skims Global